ReShape Lifesciences
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. ReShape Lifesciences's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 23% to $8,678,000. The net income raised on -$11,387,000 and profit margin reached -131%. Total operating expenses were $20,187,000.
Profit Margin
| 2014 | 0 | -26.12M | |
|---|---|---|---|
| 2015 | 292K | -25.49M | -8732.53% |
| 2016 | 786.66K | -23.36M | -2969.62% |
| 2017 | 1.28M | -33.81M | -2627.34% |
| 2018 | 606.71K | -81.15M | -13375.68% |
| 2019 | 15.08M | -74.20M | -491.8% |
| 2020 | 11.29M | -21.63M | -191.43% |
| 2021 | 13.6M | -61.93M | -455.39% |
| 2022 | 11.24M | -46.21M | -411.16% |
| 2023 | 8.67M | -11.38M | -131.22% |
RSLS Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 8.67M | 11.24M | 13.6M | 11.29M | 15.08M | 606.71K | 1.28M | 786.66K | 292K | 0 |
Cost of revenue | 3.13M | 4.43M | 5.25M | 5.03M | 5.78M | 164.29K | 936.38K | 431.47K | 125K | 0 |
Gross profit | 5.54M | 6.80M | 8.34M | 6.26M | 9.30M | 442.41K | 350.76K | 355.18K | 167K | 0 |
Operating exp. | ||||||||||
Research and development | 2.31M | 2.53M | 2.52M | 3.49M | 3.12M | 5.72M | 5.77M | 5.16M | 8.14M | 11.03M |
Selling and marketing | 7.54M | 14.09M | 9.16M | 4.69M | 4.84M | 5.23M | 0 | 0 | 0 | 0 |
Total operating expenses | 20.18M | 33.88M | 36.09M | 18.71M | 25.19M | 24.98M | 31.75M | 23.15M | 28.03M | 25.59M |
Operating income | -14.63M | -27.07M | -27.74M | -12.45M | -15.88M | -38.54M | -31.40M | -22.79M | -27.86M | -25.59M |
Other income (expenses), net | 3.30M | -19.51M | -34.29M | -9.35M | -59.21M | -14.15M | -1.37M | 3.53M | 2.36M | -535.72K |
Income before tax | -11.33M | -46.59M | -62.03M | -21.81M | -75.1M | -38.71M | -36.13M | -23.36M | -25.49M | -26.12M |
Income tax expense | 52K | -380K | -106K | -181K | -893K | -3.44M | -2.31M | 3.96M | -2.55M | 347.09K |
Net income | -11.38M | -46.21M | -61.93M | -21.63M | -74.20M | -81.15M | -33.81M | -23.36M | -25.49M | -26.12M |
Earnings per share | ||||||||||
Basic EPS | -110.88 | -108.9 | -283.42 | -48.19K | -2.36K | -6.39K | -176.00K | -8.29K | -132.81K | 0 |
Diluted EPS | -110.88 | -108.9 | -283.42 | -48.19K | -2.36K | -6.39K | -176.00K | -8.29K | -132.81K | 0 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |